Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Pathology
Dean Tantin has not added Biography.
If you are Dean Tantin and would like to personalize this page please email our Author Liaison for assistance.
Mouse lymphoid cell line selected to have high immunoglobulin promoter activity.
Molecular and cellular biology Mar, 2002 | Pubmed ID: 11839812
Regulation of immunoglobulin promoter activity by TFII-I class transcription factors.
The Journal of biological chemistry Feb, 2004 | Pubmed ID: 14645227
Embryonic lethality, decreased erythropoiesis, and defective octamer-dependent promoter activation in Oct-1-deficient mice.
Molecular and cellular biology Feb, 2004 | Pubmed ID: 14729950
Herpes simplex virus infections are arrested in Oct-1-deficient cells.
Proceedings of the National Academy of Sciences of the United States of America Feb, 2004 | Pubmed ID: 14745036
B cell development and immunoglobulin transcription in Oct-1-deficient mice.
Proceedings of the National Academy of Sciences of the United States of America Feb, 2004 | Pubmed ID: 14762167
The octamer binding transcription factor Oct-1 is a stress sensor.
Cancer research Dec, 2005 | Pubmed ID: 16322220
An inducible enhancer required for Il12b promoter activity in an insulated chromatin environment.
Molecular and cellular biology Apr, 2007 | Pubmed ID: 17242186
Oct-1 is involved in the transcriptional repression of the p15(INK4b) gene.
FEBS letters Mar, 2007 | Pubmed ID: 17316622
High-throughput biochemical analysis of in vivo location data reveals novel distinct classes of POU5F1(Oct4)/DNA complexes.
Genome research Apr, 2008 | Pubmed ID: 18212089
A general mechanism for transcription regulation by Oct1 and Oct4 in response to genotoxic and oxidative stress.
Genes & development Jan, 2009 | Pubmed ID: 19171782
Oct1 loss of function induces a coordinate metabolic shift that opposes tumorigenicity.
Nature cell biology Mar, 2009 | Pubmed ID: 19219035
An allergy-associated polymorphism in a novel regulatory element enhances IL13 expression.
Human molecular genetics Dec, 2009 | Pubmed ID: 19706623
Stem cells, stress, metabolism and cancer: a drama in two Octs.
Trends in biochemical sciences Oct, 2009 | Pubmed ID: 19733480
Oct1 is a switchable, bipotential stabilizer of repressed and inducible transcriptional states.
The Journal of biological chemistry Jan, 2011 | Pubmed ID: 21051540
Combinatorial binding of transcription factors in the pluripotency control regions of the genome.
Genome research Jul, 2011 | Pubmed ID: 21527551
Dynamic regulation of Oct1 during mitosis by phosphorylation and ubiquitination.
PloS one , 2011 | Pubmed ID: 21897860
Proliferation and metabolism: it's as easy as APC.
Cell metabolism Apr, 2012 | Pubmed ID: 22482721
Constitutive nuclear localization of NFAT in Foxp3+ regulatory T cells independent of calcineurin activity.
Journal of immunology (Baltimore, Md. : 1950) May, 2012 | Pubmed ID: 22490438
Transcription factor oct1 is a somatic and cancer stem cell determinant.
PLoS genetics Nov, 2012 | Pubmed ID: 23144633
Vitamin C Promotes Maturation of T-Cells.
Antioxidants & redox signaling Feb, 2013 | Pubmed ID: 23249337
Dynamic regulatory network controlling TH17 cell differentiation.
Nature Apr, 2013 | Pubmed ID: 23467089
Regulation of Oct1/Pou2f1 transcription activity by O-GlcNAcylation.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology Apr, 2013 | Pubmed ID: 23580612
University of Utah School of Medicine
Dean Tantin1,
Warren P. Voth1,
Arvind Shakya1
1Department of Pathology, University of Utah School of Medicine
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.